531
Participants
Start Date
December 9, 2021
Primary Completion Date
March 6, 2024
Study Completion Date
March 6, 2026
TG-C
2 mL injection of non-transduced human chondrocytes and irradiated transduced human GP2-293 cells expressing TGF-B1
Placebo Control
2 mL normal saline intraarticular injection
Jonathan Samuels, New York
Igor Grosman, Brooklyn
John Solic, Durham
Jeremy Hoff, Wilmington
Edward Tavel, Charleston
Jan Hommen, Doral
Mira Baron, West Palm Beach
Miguel Trevino, Clearwater
Priyesh Mehta, Dayton
Nathan Rimmke, Rochester Hills
Thomas Schnitzer, Chicago
Larkin Wadsworth, St Louis
Manjoo Sharma, Lewisville
Haresh Boghara, Red Oak
James Lilly, Dallas
Leonel Reyes, San Antonio
Charles Andrews, San Antonio
Richard Radnovich, Boise
Nebojsa Skrepnik, Tucson
Duane C Anderson, Las Vegas
Stuart Silverman, Beverly Hills
Samy Metyas, Covina
Peter Hanson, La Mesa
John Beckes, San Diego
Bassil Aish, Huntington Beach
Steve Sitar, Anaheim
David Scott, Spokane
Lead Sponsor
Kolon TissueGene, Inc.
INDUSTRY